Pharmacokinetics of tiotropium in asthmatic children aged 6-11 years support its safety profile

Research output: Contribution to journalLetterContributedpeer-review

Contributors

  • Ashish Sharma - , Boehringer Ingelheim GmbH (Author)
  • René Aalbers - , Martini Ziekenhuis (Author)
  • Eckard Hamelmann - , Epilepsy Center Bethel, Ruhr University Bochum (Author)
  • Stanley Goldstein - , Allergy and Asthma Care of Long Island (Author)
  • Michael Engel - , Boehringer Ingelheim GmbH (Author)
  • Petra Moroni-Zentgraf - , Boehringer Ingelheim GmbH (Author)
  • Christian Vogelberg - , Department of Paediatrics, TUD Dresden University of Technology (Author)

Details

Original languageEnglish
Pages (from-to)773-776
Number of pages4
JournalPediatric allergy and immunology
Volume29
Issue number7
Publication statusPublished - Nov 2018
Peer-reviewedYes

External IDs

PubMed 29972697

Keywords

Keywords

  • asthma, children, pharmacokinetics, tiotropium Respimat